REDDING, Calif., Jan. 21, 2025 /PRNewswire/ -- According to a new market research report, 'Tissue Engineering Market Size, Share, Forecast, & Trends Analysis by Product (Scaffold [Collagen, PLA, Stem Cells], Tissue Grafts [Allograft, Xenografts, Autografts]) Application (Musculoskeletal, Oncology, Cardiology) End User - Global Forecast to 2031,' published by Meticulous Research®.
The tissue engineering market is projected to reach $7.41 billion by 2031, at a CAGR of 18.6% during the forecast period 2024–2031.
Download FREE PDF Brochure Of Tissue Engineering Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6089
Tissue engineering is the process of repairing damaged tissues using specialized cells, materials, and bioactive molecules. It involves the development of biological substitutes to restore, maintain, and enhance tissue function. It is used in fields such as research, transplantation, and medicine to repair or replace body parts, organs, and bones.
The growth of the tissue engineering market is driven by increasing approvals for tissue engineering products, rising demand for regenerative medicine, availability of funding for product development, and the growing incidence of musculoskeletal disorders. Additionally, innovations in tissue engineering products, their integration into sports medicine, and the expanding use of tissue engineering in newer therapeutic areas are expected to create market growth opportunities.
However, high treatment costs and ethical concerns related to the use of stem cells restrain market growth. Moreover, unfavorable reimbursement policies and the complexities involved in manufacturing tissue engineering products are some of the challenges affecting market growth.
Get Insightful Data On Regions, Market Segments, Customer Landscape, And Top Companies (Charts, Tables, Figures And More) - https://www.meticulousresearch.com/request-sample-report/cp_id=6089
Government and Private Funding For Product Development Driving Market Growth
Government organizations, research institutions, and private agencies are actively supporting regenerative medicine to address healthcare needs. For instance, in November 2023, the U.S. National Science Foundation (NSF) allocated up to USD 1.6 million to fund various projects aimed at advancing tissue engineering. This financial support facilitates the development of advanced technologies, such as 3D bioprinting and regenerative therapies, among others. Such funding helps reduce development costs and strengthens the commercialization of tissue engineering products.
The key players operating in the tissue engineering market are Smith & Nephew plc (U.K.), Integra LifeSciences Holdings Corporation (U.S.), AbbVie Inc. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), Organogenesis Inc. (U.S.), Becton, Dickinson and Company (C. R. Bard) (U.S.), Baxter International Inc. (U.S.), Octane Medical Group (Canada), Tissue Regenix Group plc (U.K.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.).
Based on product, the tissue engineering market is segmented into scaffolds and tissue grafts, the scaffold segment is projected to register the highest growth rate during the forecast period of 2024–2031. This segment's growth is driven by technological advancements in biocompatible and biodegradable materials, the rising demand for customized scaffolds, the increasing incidence of chronic diseases, and growing stem cell research.
Have Specific Research Needs? Request a Customized Research Report - https://www.meticulousresearch.com/request-customization/cp_id=6089
Based on application, the global tissue engineering market is segmented into musculoskeletal & orthopedics, oncology, immunology and inflammation, neurology, dermatology, cardiology, and other applications. The Cardiology segment is projected to register the highest CAGR during the forecast period of 2024-2031. This segment's growth is driven by the rising prevalence of cardiovascular diseases globally, increased R&D activities by pharmaceutical and biotechnology companies focused on developing stem cell therapies, and advancements in tissue engineering technologies.
Based on end user, the global tissue engineering market is segmented into hospitals & clinics and ambulatory surgical centers. The hospital and clinics segment is slated to register a higher CAGR during the forecast period. Hospitals and clinics are increasingly adopting tissue engineering solutions for patient care and integrating advanced tissue engineering products into treatment plans to improve patient outcomes. The growing number of surgical and medical procedures that utilize tissue engineering products is driving the adoption of these technologies, driving market growth.
Based on geography, Asia-Pacific is projected to register the highest growth rate during the forecast period. Moreover, Japan is expected to account for the larger share of the tissue engineering market in Asia Pacific in 2024. The country's large market share can be attributed to the rising burden of clinical disorders, government initiatives aimed at establishing a robust research ecosystem, and the increasing adoption of tissue engineering and gene therapy products.
Tissue Engineering Industry Overview: Latest Developments from Key Industry Players
- In March 2024, HVD Life Science Vertriebs-GmbH (Austria) partnered with Poietis (France) for the distribution of the NGB-RTM Bioprinting platform in Austria and Germany. This collaboration brings cutting-edge bioprinting technology to the forefront of R&D in tissue engineering and regenerative medicine.
- In October 2023, Smith & Nephew plc (U.K.) launched the REGENETEN Bioinductive Implant in Japan. This wound care patch supports new tendon-like tissue growth and initiates biological tendon regeneration.
- In May 2022, Darling International Inc. (U.S.) health brand Rousselot launched a Quali-Pure HGP 2000, a new pharmaceutical-grade, endotoxin-controlled gelatin specifically designed for vaccines and wound healing applications.
- In February 2022, Orthofix Medical Inc. (U.S.) launched an Opus BA, a synthetic bioactive bone graft solution for cervical and lumbar spine fusion procedures.
IMMEDIATE DELIVERY AVAILABLE | BUY THIS RESEARCH REPORT (Insights, Charts, Tables, Figures and More)- https://www.meticulousresearch.com/Checkout/29386651
Scope of the Report:
Tissue Engineering Market Assessment—by Product
- Scaffold
- Biologically Derived Material
- Collagen
- Hydrogel
- Stem Cells
- Other Biologically Derived Materials
- Biologically Derived Material
- Synthetic Material
- Poly (Propylene Fumarate) (PPF)
- Polylactic Acid (PLA)
- Poly (Glycolic Acid) (PGA)
- Polycaprolactone (PCL)
- Other Synthetic Materials
Note: Other Biologically Derived Materials include Chitosan, Fibrinogen, and Hyaluronan.
Other Synthetic Materials include Polymethyl Methacrylate (PMMA) and Poly (Lactic-Co-Glycolic) Acid (PLGA)
- Tissue Grafts
- Allograft
- Autograft
- Synthetic Grafts
- Xenograft
Tissue Engineering Market Assessment—by Application
- Musculoskeletal & Orthopedics
- Oncology
- Immunology And Inflammation
- Neurology
- Dermatology
- Cardiology
- Other Applications
Note: Other Applications include Wound Care, Urology, and Gynecology
Tissue Engineering Market Assessment—by End User
- Hospitals And Clinics
- Ambulatory Surgical Centers
Tissue Engineering Market Assessment—by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Switzerland
- Netherlands
- Sweden
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Related Reports –
Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), and End user - Global Forecast to 2029 - https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971
North America Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), and End User - Forecast to 2030 - https://www.meticulousresearch.com/product/north-america-tissue-diagnostics-market-5554
3D Cell Culture Market by Product (Low Attachment Surfaces, Bioreactors, Hanging Drop Method, Hydrogel, Porous Scaffold, Fibrous Scaffold), Application (Cancer Research, Regenerative Medicine, Tissue Engineering, Drug Discovery) - Global Forecast to 2030 - https://www.meticulousresearch.com/product/3d-cell-culture-market-1246
Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering) Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology) End User - Global Forecast to 2031 - https://www.meticulousresearch.com/product/regenerative-medicine-market-5864
Biomaterials Market By Material Type [(Metal (Alloy, Pure Metal), Ceramic (Inert, Bioresorbable), Polymer, Natural Materials, Composites)], And Application (Heart Disease, Orthopedic, Opthalmic, Dental Application, Neurostimulator) - Global Forecast to 2023 - https://www.meticulousresearch.com/product/biomaterials-market-4270
Synthetic Biology Market Size, Share, Forecast, & Trends Analysis by Product (Enzymes, Oligonucleotide, DNA) Technology (Gene Synthesis, Genome Editing, Sequencing, Cloning) Application (Life Sciences, Chemical, Food) End User – Global Forecast to 2031 - https://www.meticulousresearch.com/product/synthetic-biology-market-5826
Chitosan Market Size, Share, Forecast, & Trends Analysis by Source (Shrimps, Prawns, Crabs, Fungi), Grade (Industrial, Food, Pharmaceutical), Application (Biomedical and Pharmaceutical, Water Treatment, Cosmetics, Food & Beverage) - Global Forecast to 2031 - https://www.meticulousresearch.com/product/chitosan-market-6106
Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, academic) - Global Forecast to 2029 - https://www.meticulousresearch.com/product/cell-culture-market-4788
Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Media, Disposables, Centrifuge, Filtration System), Cell Type (Human, Animal), Technology (Filtration, Surface Marker), Application (Research, Therapeutics), End User- Global Forecast to 2024 - https://www.meticulousresearch.com/product/cell-Isolation-cell-separation-market-4966
Cell Culture Media Market by Product (Serum-free, Chemically Defined, Classical, Xeno-free/Animal Component Free), Application (Monoclonal Antibody, Diagnostics, Cancer and Stem Cell Research), End User (Pharma & Biotech, Academic)- Global Forecast to 2029 - https://www.meticulousresearch.com/product/cell-culture-media-market-5318
Cell Culture Reagents Market by Product (Growth Factors and Cytokines, Supplement, Cryoprotective, Antibiotic, Buffer), Application (Bioproduction (Antibody, Protein, Vaccine), Research, Diagnostics), End User (Pharma, Academic) - Global Forecast to 2029 - https://www.meticulousresearch.com/product/cell-culture-reagents-market-5322
CAR T-cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene maraleucel], Yescarta [axicabtagene ciloleucel]), Target Antigen (CD, BCMA, HER2), Indication (Lymphoma, ALL, AML, Multiple Myeloma) - Global Forecast to 2030 - https://www.meticulousresearch.com/product/car-t-cell-therapy-market-5508
Competent Cells Market by Type (Cloned Competent Cells, Agrobacterium Tumefaciens Competent Cells, and Expression Competent Cells), Treatment (Chemically Competent Cells and Electrocompetent Cells), Application (Cloning, Protein Expression, others), and by End User (Pharmaceutical and Biotechnology Industry, Academic and Research Institutes, and Contract Research Organizations) - Global Forecasts to 2023 - https://www.meticulousresearch.com/product/competent-cells-market-forecast-2023-3723
Nurse Call Systems Market Size, Share, Forecast, & Trends Analysis by Type (Button System, Mobile Call, Intercom, Software) Technology (Wired, Wireless, Hybrid) Application (Fall detection, Location Tracking, Emergency Alarm) End User – Global Forecast to 2031 - https://www.meticulousresearch.com/product/nurse-call-systems-market-5906
Tissue Engineering Market Research Summary -
Particulars | Details |
Number of Pages | 187 |
Format | |
Forecast Period | 2024–2031 |
Base Year | 2023 |
CAGR (Value) | 18.6 % |
Market Size (Value) | USD 7.41 Billion by 2031 |
Segments Covered | By Product
By Application
By End User
|
Countries Covered | North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Sweden, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
Key Companies | Smith & Nephew plc (U.K.), Integra LifeSciences Holdings Corporation (U.S.), AbbVie Inc. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), Organogenesis Inc. (U.S.), Becton, Dickinson and Company (C. R. Bard) (U.S.), Baxter International Inc. (U.S.), Octane Medical Group (Canada), Tissue Regenix Group plc (U.K.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.) |
About Meticulous Research Pvt. Ltd.
We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. Each year, we conduct over 300 syndicated studies and manage 60+ consulting engagements across eight major sectors and 20+ geographic markets, all to deliver targeted business insights that help our clients lead in a rapidly evolving global market.
With a strong focus on problem-solving for complex business challenges, our research enables organizations to navigate change with assertion, aligning it with strategic pathways for sustainable growth. By identifying innovative and effective solutions, we empower leaders to make impactful decisions that drive operational excellence and fuel innovation. We are committed to crafting insights that enhance business performance and help our clients unlock new revenue opportunities, positioning them for long-term success in the competitive global marketplace.
Contact:
Meticulous Market Research Pvt.Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Meticulousblog.org | Top Market Research Reports Blog - https://meticulousblog.org/
Content Source: https://www.meticulousresearch.com/pressrelease/1325/tissue-engineering-market
Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original content:
Voltar noticias em Inglês